The New Hyde Park, N.Y.-based health system will provide digital care to patients by offering access to Pear’s reSET and reSET-O. They are the first prescription digital therapy to be FDA-approved to treat disease. They use game-like visual simulations to make permanent changes in the visual cortex and offer an alternative to traditional prescription drugs.
The program will be offered through Northwell’s standalone behavioral health facility, Zucker Hillside Hospital. Both products work with outpatient counseling and provide patients with algorithm-driven cognitive behavioral therapy and contingency management, while therapists can access this data to inform in-office and telehealth visits.
“We are witnessing a substantial increase in substance misuse and opioid overdose death as a result of the social isolation, anxiety and stress related to COVID-19,” said Bruce Goldman, director of behavioral health at Northwell Health. “Northwell Health has successfully transformed our ambulatory substance use treatment services to a telehealth model. To augment our treatment services, we have made available to our patients this FDA-authorized prescription digital therapeutic proven to increase the retention of patients in outpatient treatment programs.”
More articles on digital transformation:
Salesforce, Conifer & more: 7 recent exec moves in digital health
Weill Cornell physicians testing prescription video game to curb COVID-19 brain fog
Google launches AI call center in 28 languages to promote vaccine equity, help public health leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.